Type 2 & other diabetes

Cardiac vagal activity is associated with insulin metabolism in heart failure: Results from the Myovasc study

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

This study demonstrates the relevance of insulin status for vagal activity of cardiac autonomic function, particularly in heart failure. The pathophysiological implications underlying the relationship between insulin status and parasympathetic activity merit further mechanistic exploration.

Study context

Population
Individuals of the MyoVasc heart failure cohort in a fasting state; median age 64.0 years, 33% women; symptomatic HF in 43.7%
Participants
1,588 individuals
Exposure
HbA1c, HOMA-IR and C-peptide vs parasympathetic reactivation
Outcome
Heart rate recovery 60 s (HRR60) after cardiopulmonary exercise testing
Methodological detailscross-sectional and longitudinal analyses, multivariable linear regression
  • Cross-sectional and longitudinal analyses
  • Multivariable linear regression

Main finding

As reported in the abstract

Association with HRR60 (adjusted for age, sex, clinical profile, medication)
Median HRR60, beats per minute (IQR 14.0;28.0)
21.0
HbA1c, β per SD (95% CI −0.122;−0.026), P = 0.003
−0.074
HOMA-IR, β per SD (−0.165;−0.062), P < 0.0001
−0.113
HOMA-IR additionally adjusted for glucose status, β per SD (−0.155;−0.040), P < 0.0001
−0.097
HbA1c additionally adjusted for insulin status, β per SD (−0.084;0.025), P = 0.28
−0.030
C-peptide, independent of HbA1c, β per SD (−0.225;−0.117), P < 0.0001
−0.171

Observational data: associations, not effects.

Further findings

Subgroups with HF and T2D

HOMA-IR, but not HbA1c, independently related to HRR60 confirmed in subgroups with HF and T2D

Association with lower HRR60 at follow-up · two years

Higher HbA1c, β per SD (−0.171;−0.017), P = 0.017
−0.094
Higher C-peptide, β per SD (−0.159;0.007), P = 0.075
−0.076

Original publication

Cardiac vagal activity is associated with insulin metabolism in heart failure: Results from the Myovasc study. Cardiovasc Diabetol. Published 8 January 2026. doi:10.1186/s12933-025-03040-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.